Galderma Group AG (SWX:GALD)
Switzerland · Delayed Price · Currency is CHF 170.95
+1.35 (0.80%)
Aug 19, 2026, 5:31 PM CET
Galderma Group AG Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 5,923 | 5,241 | 4,440 | 4,117 | 3,824 | 3,445 |
Revenue Growth | 13.01% | 18.04% | 7.85% | 7.66% | 11.00% | - |
Gross Profit Gross Profit Growth | 4,109 | 3,609 | 3,085 | 2,885 | 2,630 | 2,411 |
Operating Income Operating Income Growth | 1,131 | 885 | 671 | 606 | 400.9 | 349.5 |
Net Income Net Income Growth | 863 | 613 | 231 | -57 | -98.5 | -154.3 |
Earnings Per Share EPS Growth | 3.65 | 2.58 | 0.97 | -0.24 | -0.02 | -0.03 |
EPS Growth | 41.57% | 165.98% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Neuromodulators Neuromodulators Growth | 1,590 | 1,471 | 1,285 | 1,162 | 1,002 | 792.9 |
Fillers & Biostimulators Fillers & Biostimulators Growth | 1,178 | 1,101 | 1,014 | 966 | 990.1 | 881.1 |
Dermatological Skincare Dermatological Skincare Growth | 1,578 | 1,449 | 1,331 | 1,212 | 1,089 | 861 |
Therapeutic Dermatology Therapeutic Dermatology Growth | 1,544 | 1,185 | 780 | 741.7 | 679.4 | 882 |
Revenue (Total) Revenue (Total) Growth | 5,923 | 5,241 | 4,440 | 4,117 | - | - |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 839 | 780 | 457 | 368 | 234.1 | 287.2 |
Total Debt Total Debt Growth | 2,716 | 2,754 | 2,759 | 4,909 | 5,658 | 5,689 |
Net Cash (Debt) Net Cash Growth | -1,877 | -1,974 | -2,302 | -4,541 | -5,424 | -5,401 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -7.97 | -8.33 | -9.68 | -19.11 | -1.05 | -1.04 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1,206 | 1,185 | 488 | 165 | 111.3 | 195.7 |
Capital Expenditures CapEx Growth | -126 | -113 | -128 | -121 | -101.6 | -49.9 |
Free Cash Flow Free Cash Flow Growth | 1,080 | 1,072 | 360 | 44 | 9.7 | 145.8 |
Free Cash Flow Growth | 0.75% | 197.78% | 718.18% | 353.61% | -93.35% | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 69.37% | 68.86% | 69.48% | 70.08% | 68.77% | 69.99% |
Operating Margin | 19.10% | 16.89% | 15.11% | 14.72% | 10.48% | 10.14% |
Pretax Margin | 15.89% | 12.19% | 6.98% | 0.27% | -1.36% | -2.31% |
Profit Margin | 14.57% | 11.70% | 5.20% | -1.39% | -2.58% | -4.48% |
FCF Margin | 18.23% | 20.45% | 8.11% | 1.07% | 0.25% | 4.23% |
| Fiscal Year | Current | FY 2025 | FY 2024 |
|---|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 |
Dividend Per Share Dividend Per Share Growth | 0.350 | 0.441 | 0.166 |
Dividend Per Share Growth | 0% | 166.65% | - |
Dividend Yield | 0.21% | 0.22% | 0.15% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 19, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 57.47 | 79.17 | 114.22 | - | - | - |
Forward PE | 37.06 | 49.03 | 43.27 | - | - | - |
P/FCF Ratio | 45.32 | 45.27 | 73.29 | - | - | - |
PS Ratio | 8.26 | 9.26 | 5.94 | - | - | - |